[Abstract Only] Study: Comparison of amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders
18 Oct, 2020 | 23:00h | UTCAmisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
“In this pragmatic, long-term, semi-randomised trial, we compared the #antipsychotic efficacy of amisulpride, aripiprazole, and olanzapine.”
New research: The BeST InTro trialhttps://t.co/r0AVfzFgnB
— The Lancet Psychiatry (@TheLancetPsych) October 16, 2020